Featured Posters & Presentations
Lyfgenia
Recent progress in gene therapy for severe sickle cell disease: Updated interim results from a Phase 1 clinical study of LentiGlobin gene therapy.
Authors: Kanter J.
Zynteglo
LentiGlobin gene therapy for transfusion-dependent β-thalassemia (TDT) in patients with non-β0/β0 genotypes: updated results from Northstar-2.
Authors: Locatelli F.